FGC Health Names Timothy Wilde as Chief Digital Officer, Expands Focus on Technology to Transform Health Services

Healthcare industry veteran to oversee digital solutions acceleration WINNIPEG, Manitoba–(BUSINESS WIRE)–FGC Health, a leader in consumer health services, industry-specific business tools, and provider of an industry-leading proprietary open-source platform, today announced that Timothy Wilde has joined the leadership team as Chief Digital Officer. Wilde most recently served as CTO for EXL Health where he led … [Read more…]

Amneal to Report Third Quarter 2022 Results on November 4, 2022

BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its third quarter 2022 financial results on Friday November 4, 2022, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on November 4, 2022. The financial results … [Read more…]

Aldeyra Therapeutics Achieves Primary Endpoint in Part 1 of Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy

ADX-2191 Statistically Superior to Historical Control for Primary Endpoint of Prevention of Retinal Detachment (P=0.024) Numerical Superiority of ADX-2191 over Routine Surgical Care Achieved for Majority of Secondary, Exploratory, and Safety Endpoints ADX-2191 Observed to be Well Tolerated with No Safety Concerns Noted Company Plans to Discuss Completion of Clinical Development in Proliferative Vitreoretinopathy with … [Read more…]

Rectify Pharmaceuticals Appoints Robert Hughes as Executive Vice President, Drug Discovery and Preclinical Development, and Xiaobing Li as Chief Development Officer

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company developing small molecule disease-modifying therapeutics that restore and enhance ABC transporter function, continues to grow its senior leadership team. Robert Hughes, Ph.D., recently joined as Executive Vice President of Drug Discovery and Preclinical Development and Xiaobing Li, Ph.D., joins as Chief Development Officer. “We are extremely … [Read more…]

The GEO Group Publishes Fourth Annual Human Rights and ESG Report

BOCA RATON, Fla.–(BUSINESS WIRE)–The GEO Group, Inc. (NYSE: GEO) (“GEO” or the “Company”) published today the company’s fourth annual Human Rights and Environmental, Social & Governance (ESG) report. The report includes enhanced disclosures related to our Board oversight of human rights and ESG matters, employee diversity and training programs, corporate governance, and environmental sustainability, including … [Read more…]

Global Topical Pain Relief Market Report 2022: Rising Demand Among Athletes for Topical Analgesics Spurs Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Topical Pain Relief Market Analysis by Formulation, by Type (Prescription Pain Reliefs, Over-The-Counter Pain Reliefs), by Distribution Channel, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The less adverse effects than those of traditional oral medications, rising demand among athletes for topical analgesics, increase in the … [Read more…]

The Worldwide Endosurgery Device Industry is Expected to Reach $7.1 Billion by 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Endosurgery Device Market Research Report by Product (Electrosurgical Device and Endomechanical Device), Application, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The Global Endosurgery Device Market size was estimated at USD 4,952.38 million … [Read more…]

US Multiple Myeloma Market and Competitive Landscape – 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “US Multiple Myeloma Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report US Multiple Myeloma Market and Competitive Landscape Highlights – 2022, provides comprehensive insights into Multiple Myeloma pipeline products, Multiple Myeloma epidemiology, Multiple Myeloma market valuations and forecast, Multiple Myeloma drugs sales and competitive landscape in … [Read more…]

Global Biocomposites Markets Report 2023-2033 with Profiles of 150+ Companies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The Global Market for Biocomposites 2023-2033” report has been added to ResearchAndMarkets.com’s offering. Biocomposites are generally referred to as composites with either reinforcement or matrix derived from natural sources, or encompassing both (full biocomposites). Biocomposites are produced from naturally-renewable and abundant precursor feedstocks, and possess properties equivalent, on a weight basis, to their … [Read more…]

Dipharma Receives Regulatory Authorization for the New Line at Its cGMP Pilot Plant

Thanks to the approval by the Italian Medicines Agency (AIFA), the Company increases its efficiency and is able to face the growing demand for its services. MILAN–(BUSINESS WIRE)–#AIFA–Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active Pharmaceutical Ingredients, announced today that the Italian Medicines Agency (AIFA) … [Read more…]